COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS, IN COLOMBIA

被引：0
|
作者：
Gamboa, O. [1 ]
Barbosa, D. [2 ]
Parada, L. [3 ]
Latorre, M. [4 ]
机构：
[1] IECAS, Bogota, Colombia
[2] F Hoffmann La Roche, Bogota, Colombia
[3] Roche Colombia, Bogota, DC, Colombia
[4] Prod Roche Colombia, Bogota, Colombia
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1490
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A563 / A563
页数：1
相关论文
共 50 条
  • [1] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Diamantopoulos, Alex
    Finckh, A.
    Huizinga, T.
    Sungher, D. K.
    Sawyer, L.
    Neto, D.
    Dejonckheere, F.
    PHARMACOECONOMICS, 2014, 32 (08) : 775 - 787
  • [2] Tocilizumab in the Treatment of Rheumatoid Arthritis: A Cost-Effectiveness Analysis in the UK
    Alex Diamantopoulos
    A. Finckh
    T. Huizinga
    D. K. Sungher
    L. Sawyer
    D. Neto
    F. Dejonckheere
    PharmacoEconomics, 2014, 32 : 775 - 787
  • [3] COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
    Oksuz, E.
    Malhan, S.
    Yanik, L.
    Koc, E.
    Erdogan-Ciftci, E.
    Celik, H.
    Orfanos, P.
    VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [4] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB VERSUS INFLIXIMAB FOR THE PATIENTS WITH RHEUMATOID ARTHRITIS IN KAZAKHSTAN
    Bektur, C.
    Kayir, F.
    Nurgozhin, T.
    VALUE IN HEALTH, 2014, 17 (07) : A379 - A379
  • [5] COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB WITHOUT METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
    Oksuz, E.
    Malhan, S.
    Yanik, L.
    Koc, E.
    Erdogan-Ciftci, E.
    Celik, H.
    Orfanos, P.
    VALUE IN HEALTH, 2018, 21 : S297 - S297
  • [6] COST-EFFECTIVENESS OF ABATACEPT OR INFLIXIMAB IN RHEUMATOID ARTHRITIS IN COLOMBIA
    Alfonso-Cristancho, R.
    Aiello, E. C.
    Roa, C. N.
    VALUE IN HEALTH, 2011, 14 (03) : A127 - A127
  • [7] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SUBCUTANEOUSCOMBOTHERAPY FIRST LINE FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS IN GREECE
    Athanasakis, K.
    Tarantilis, F.
    Skroumpelos, A.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2016, 19 (07) : A538 - A538
  • [8] COST-EFFECTIVENESS OF TOCILIZUMAB FOR THE MANAGEMENT OF INADEQUATELY RESPONDING RHEUMATOID ARTHRITIS PATIENTS
    Hansen, R. N.
    Best, J. H.
    Sullivan, S. D.
    Carlson, J. J.
    VALUE IN HEALTH, 2015, 18 (03) : A161 - A161
  • [9] Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran
    Metghalchi, Yalda
    Yaghoubi, Neda
    Yousefi, Nazila
    Ahmadi, Razieh
    Kargar, Alireza
    Zargaran, Marzieh
    Rezaei, Soheila
    COST EFFECTIVENESS AND RESOURCE ALLOCATION, 2024, 22 (01):
  • [10] COST-EFFECTIVENESS ANALYSIS OF TOCILIZUMAB SUBCUTANEOUS AS FIRST LINE BIOLOGIC MONOTHERAPY FOR RHEUMATOID ARTHRITIS MANAGEMENT IN GREECE
    Athanasakis, K.
    Tarantilis, F.
    Skroumpelos, A.
    Kyriopoulos, J.
    VALUE IN HEALTH, 2015, 18 (07) : A671 - A671
12345